Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.38 |
| ▸ | ALPI | P09923 | 1/20 | 0.38 |
| ▸ | ALPG | P10696 | 1/20 | 0.38 |
| ▸ | PLAA | Q9Y263 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.36 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5138925 | 0.77 | SRC (0.40) | SRCPOLBHPGDALPIALPG | |
| SCHEMBL31054978 | 0.73 | KMT2A (0.48) | SRCPOLBHPGDALPIALPG | |
| SCHEMBL31055021 | 0.73 | SRC (0.45) | SRCPOLBHPGDALPIALPG | |
| SCHEMBL31055029 | 0.73 | POLB (0.56) | SRCPOLBALPIALPGPLAA | |
| SCHEMBL8986686 | 0.73 | SRC (0.45) | SRCPOLBHPGDALPIALPG | |
| SCHEMBL5139377 | 0.72 | SRC (0.43) | SRCPOLBHPGDALPIALPG | |
| SCHEMBL31489893 | 0.70 | PDK2 (0.45) | SRCPDK2 | |
| SCHEMBL5138924 | 0.70 | POLB (0.45) | SRCPOLBALPIALPGPLAA | |
| SCHEMBL100362 | 0.69 | GRM4 (0.58) | — | |
| SCHEMBL29540471 | 0.69 | GRM4 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7345080-B2 | Substituted 4-pyrazolyl pyrazonlines used for pest control | BAYER CROPSCIENCE AG (DE) | 2008-03-18 | — | — | US | disclosed |
| US-20050159603-A1 | Substituted 4-pyrazolyl pyrazonlines used for pest control | BAYER CROPSCIENCE AG (DE) | 2005-07-21 | — | — | US | disclosed |
| EP-1478644-A1 | SUBSTITUTED 4-PYRAZOLYL PYRAZOLINES USED FOR PEST CONTROL | Bayer CropScience AG (DE) | 2004-11-24 | — | — | EP | disclosed |
| WO-2003070724-A1 | SUBSTITUTED 4-PYRAZOLYL PYRAZOLINES USED FOR PEST CONTROL | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2003-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159603-A1 | Substituted 4-pyrazolyl pyrazonlines used for pest control | L3MBTL4, L3MBTL3, PTMS | SRC 3552/4885POLB 4747/4885HPGD 4084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.